MedTrace Logo

Registry of Patients With Von WilLEbrand Disease Treated With Voncento®

NCT04657887 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 135

Last updated 2024-04-19

No results posted yet for this study

Summary

Description of the long-term evolution of patients with von Willebrand disease and treated with Voncento® and of the hemostatic efficacy in the prevention and the treatment of non-surgical bleeding episodes and prevention of surgical bleeding during 2 years after patient inclusion.

Conditions

  • Von Willebrand Disease

Interventions

BIOLOGICAL

Voncento®

Solution for injection

Sponsors & Collaborators

  • CSL Behring

    lead INDUSTRY

Principal Investigators

  • Study Director · CSL Behring SA

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-23
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04657887 on ClinicalTrials.gov